b6
14
4e
8
1d
2d
8
27
8
8
32
19
9
4c Jeffrey D Bradley
49 16
19
1
49
2
8
1b
1d
18
89
40
1d
2 29
1d
25
40
Jeffrey D Bradley, MD, FACR, FASTRO
76Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
7
69
Department: Radiation Oncology
4
1
b
1d
46
Contact information
49
4
3
3
3
2
4
b
1f
49
3400 Civic Center Boulevard
31 2nd Floor West
Philadelphia, PA 19104
26
31 2nd Floor West
Philadelphia, PA 19104
35
f
13
Education:
21 7 BA 14 (Biology) c
26 Drury College, 1989.
21 7 MD c
2f University of Arkansas, 1993.
c
3
3
3
3
92
Permanent link21 7 BA 14 (Biology) c
26 Drury College, 1989.
21 7 MD c
2f University of Arkansas, 1993.
c
2 29
21
1e
1d
24
2b
29
27
23
146 Jacob S Hogan 1, John C Baumann 2, Neha Vapiwala 3, Jeff M Michalski 4, Benjamin W Fischer-Valuck 5, Patty Karraker 4, Minesh P Mehta 6, Jeffrey D Bradley 3, Brian C Baumann : Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology. Pract Radiat Oncol 1f June 2025.
12e Feng-Ming Spring Kong 1, Chen Hu 1, Jeffrey D Bradley 1, Mitchell Machtay 1: Reply to: Mid-Treatment Positron Emission Tomography-Adaptive Radiotherapy in Stage III Non-Small Cell Lung Cancer: Another Attempt Toward Personalized Care. J Clin Oncol 1f June 2025.
294 Yvonne L B Klaver 1, Mischa S Hoogeman 2, Q Richard Lu 3, Jeffrey D Bradley 4, J Isabelle Choi 5, Matthew J Ferris 6, Cai Grau 7, Chandan Guha 8, Haibo Lin 9, Liyong Lin 10, Anthony E Mascia 11, Astrid M Moerman 12, Per R Poulsen 13, Lewis Z Shi 14, Brita Singers Sørensen 15, Sibo Tian 10, Marie-Catherine Vozenin 16, Christopher D Willey 17, Sumin Zhou 18, Richard A Amos 19, Maria Hawkins 20, Charles B Simone 2nd 5: Requirements and Study Design for the Next Proton FLASH Clinical Trials: an International Multidisciplinary Delphi Consensus. Int J Radiat Oncol Biol Phys March 2025.
159 Ioannis I Verginadis 1, Deborah E Citrin 2, Bonnie Ky 3, Steven J Feigenberg 4, Alexandros G Georgakilas 5, Christine E Hill-Kayser 6, Constantinos Koumenis 4, Amit Maity 7, Jeffrey D Bradley 4, Alexander Lin 4: Radiotherapy toxicities: mechanisms, management, and future directions. Lancet 1a 2025.
2b5 Sukhmani Kaur Padda, Mary Weber Redman, David E. Gerber, Katherine Minichiello, Dhaval R. Mehta, Sandeep H. Mashru, Hosam Hakim, Julie R. Brahmer, Jeffrey D. Bradley, Tom Stinchcombe, Jhanelle E. Gray, Karen Kelly, David E. Kozono, Karen L. Reckamp, Martin Joseph Edelman, Hossein Borghaei, Jyoti D. Patel, Roy S. Herbst, Suresh S. Ramalingam, and Joel W. Neal: A phase II study examining impact of co-mutations on sotorasib for previously treated stage IV/recurrent KRAS G12C mutated (MUT) non-squamous (Non-sq) non-small cell lung cancer (NSCLC) (ECOG-ACRIN led Lung-MAP Sub-study). Journal of Clinical Oncology 2025.
1c1 Mingdong Fan 1, Tonghe Wang 2, Yang Lei 3, Pretesh R Patel 1, Sean Dresser 1, Beth Bradshaw Ghavidel 1, Richard L J Qiu 1, Jun Zhou 1, Kirk Luca 1, Oluwatosin Kayode 1, Jeffrey D Bradley 4, Xiaofeng Yang 1, Justin Roper 1: Evaluation and failure analysis of four commercial deep learning-based autosegmentation software for abdominal organs at risk. J Appl Clin Med Phys 2025.
16d Jenna Rocchetti 1, Nikhil Yegya-Raman 1, Michelle Iocolano 1, William P Levin 1, Keith A Cengel 1, Jeffrey Bradley 1, Steven J Feigenberg 1, Cole Friedes 2: Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy. Radiother Oncol 1a 2025.
137 Jacob S Hogan, John C Baumann, Neha Vapiwala, Jeff M Michalski, Benjamin W Fischer-Valuck 5, Patty Karraker, Minesh P Mehta, Jeffrey D Bradley, Brian C Baumann : Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology. ract Radiat Oncol 1b . 2025.
293 Steven J. Feigenberg, Ceylan Tanes, Kyle Bittinger, Roddy O’Connor, Divyansh Agarwal,Giorgos Skoufos,Silvano Salaris,Artemis Hatzigeorgiou,Nektarios Kostopoulos, Shane Lloyd,Cole Friedes, Lisha Chen, Nikhil Yegya-Raman, Keith Cengel, William Levin,Bakir Valentić, Tyler Quarton,Alexander A. Shestov,Abigail Berman,Jeffrey Bradley,Amit Maity, eCostantinos Koumenis, Edgar Ben-Josef,Andrea Facciabene: Immune System Modulation with Oral Vancomycin in combination with Stereotactic Body Radiotherapy (SBRT) for medically inoperable Early-Stage Non-small Cell Lung Cancer. medrxiv 2025.
2c
7
1d
1f
Selected Publications
1b1 Tiffany Kei 1, Kirk Luca 2, Oluwatosin Kayode 2, Kristin A Higgins 2, Jeffrey D Bradley 3, Joseph W Shelton 2, Ashish B Patel 2, Xiaofeng Yang 2, Eduard Schreibmann 2, Jiahan Zhang 2, Aparna H Kesarwala 4, Justin Roper 5: Improving Lung Stereotactic Body Radiation Therapy Dose Conformity Using a Simple Noncoplanar Volumetric Modulated Arc Therapy Technique. Pract Radiat Oncol 1f July 2025.146 Jacob S Hogan 1, John C Baumann 2, Neha Vapiwala 3, Jeff M Michalski 4, Benjamin W Fischer-Valuck 5, Patty Karraker 4, Minesh P Mehta 6, Jeffrey D Bradley 3, Brian C Baumann : Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology. Pract Radiat Oncol 1f June 2025.
12e Feng-Ming Spring Kong 1, Chen Hu 1, Jeffrey D Bradley 1, Mitchell Machtay 1: Reply to: Mid-Treatment Positron Emission Tomography-Adaptive Radiotherapy in Stage III Non-Small Cell Lung Cancer: Another Attempt Toward Personalized Care. J Clin Oncol 1f June 2025.
294 Yvonne L B Klaver 1, Mischa S Hoogeman 2, Q Richard Lu 3, Jeffrey D Bradley 4, J Isabelle Choi 5, Matthew J Ferris 6, Cai Grau 7, Chandan Guha 8, Haibo Lin 9, Liyong Lin 10, Anthony E Mascia 11, Astrid M Moerman 12, Per R Poulsen 13, Lewis Z Shi 14, Brita Singers Sørensen 15, Sibo Tian 10, Marie-Catherine Vozenin 16, Christopher D Willey 17, Sumin Zhou 18, Richard A Amos 19, Maria Hawkins 20, Charles B Simone 2nd 5: Requirements and Study Design for the Next Proton FLASH Clinical Trials: an International Multidisciplinary Delphi Consensus. Int J Radiat Oncol Biol Phys March 2025.
159 Ioannis I Verginadis 1, Deborah E Citrin 2, Bonnie Ky 3, Steven J Feigenberg 4, Alexandros G Georgakilas 5, Christine E Hill-Kayser 6, Constantinos Koumenis 4, Amit Maity 7, Jeffrey D Bradley 4, Alexander Lin 4: Radiotherapy toxicities: mechanisms, management, and future directions. Lancet 1a 2025.
2b5 Sukhmani Kaur Padda, Mary Weber Redman, David E. Gerber, Katherine Minichiello, Dhaval R. Mehta, Sandeep H. Mashru, Hosam Hakim, Julie R. Brahmer, Jeffrey D. Bradley, Tom Stinchcombe, Jhanelle E. Gray, Karen Kelly, David E. Kozono, Karen L. Reckamp, Martin Joseph Edelman, Hossein Borghaei, Jyoti D. Patel, Roy S. Herbst, Suresh S. Ramalingam, and Joel W. Neal: A phase II study examining impact of co-mutations on sotorasib for previously treated stage IV/recurrent KRAS G12C mutated (MUT) non-squamous (Non-sq) non-small cell lung cancer (NSCLC) (ECOG-ACRIN led Lung-MAP Sub-study). Journal of Clinical Oncology 2025.
1c1 Mingdong Fan 1, Tonghe Wang 2, Yang Lei 3, Pretesh R Patel 1, Sean Dresser 1, Beth Bradshaw Ghavidel 1, Richard L J Qiu 1, Jun Zhou 1, Kirk Luca 1, Oluwatosin Kayode 1, Jeffrey D Bradley 4, Xiaofeng Yang 1, Justin Roper 1: Evaluation and failure analysis of four commercial deep learning-based autosegmentation software for abdominal organs at risk. J Appl Clin Med Phys 2025.
16d Jenna Rocchetti 1, Nikhil Yegya-Raman 1, Michelle Iocolano 1, William P Levin 1, Keith A Cengel 1, Jeffrey Bradley 1, Steven J Feigenberg 1, Cole Friedes 2: Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy. Radiother Oncol 1a 2025.
137 Jacob S Hogan, John C Baumann, Neha Vapiwala, Jeff M Michalski, Benjamin W Fischer-Valuck 5, Patty Karraker, Minesh P Mehta, Jeffrey D Bradley, Brian C Baumann : Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology. ract Radiat Oncol 1b . 2025.
293 Steven J. Feigenberg, Ceylan Tanes, Kyle Bittinger, Roddy O’Connor, Divyansh Agarwal,Giorgos Skoufos,Silvano Salaris,Artemis Hatzigeorgiou,Nektarios Kostopoulos, Shane Lloyd,Cole Friedes, Lisha Chen, Nikhil Yegya-Raman, Keith Cengel, William Levin,Bakir Valentić, Tyler Quarton,Alexander A. Shestov,Abigail Berman,Jeffrey Bradley,Amit Maity, eCostantinos Koumenis, Edgar Ben-Josef,Andrea Facciabene: Immune System Modulation with Oral Vancomycin in combination with Stereotactic Body Radiotherapy (SBRT) for medically inoperable Early-Stage Non-small Cell Lung Cancer. medrxiv 2025.
2c